Drug Approval | January 26, 2024
Strides receives USFDA approval for Pregabalin Capsules
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth
Subscribe To Our Newsletter & Stay Updated
